Skip to main content
Erschienen in: Immunologic Research 6/2018

04.12.2018 | Hypothesis

Review of the “X chromosome-nucleolus nexus” hypothesis of autoimmune diseases with an update explaining disruption of the nucleolus

verfasst von: Wesley H. Brooks

Erschienen in: Immunologic Research | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

The “X chromosome-nucleolus nexus” hypothesis provides a comprehensive explanation of how autoantibodies can develop following cellular stress. The hypothesis connects autoimmune diseases with the impact of environmental factors, such as viruses, through epigenetic disruption. The inactive X chromosome, a major epigenetic structure in the female cell’s nucleus, is a key component of the hypothesis. The inactive X is vulnerable to disruption due to the following: (1) its heavy requirements for methylation to suppress gene expression, (2) its peripheral location at the nuclear envelope, (3) its late replication timing, and (4) its frequently observed close association with the nucleolus. The dynamic nucleolus can expand dramatically in response to cellular stress and this could disrupt the neighboring inactive X, particularly during replication, leading to expression from previously suppressed chromatin. Especially vulnerable at the surface of the inactive X chromosome would be genes and elements from Xp22 to the terminus of the short arm of the X. Expression of these genes and elements could interfere with nucleolar integrity, nucleolar efficiency, and future nucleolar stress response, and even lead to fragmentation of the nucleolus. Ribonucleoprotein complexes assembled in the nucleolus could be left in incomplete states and inappropriate conformations, and/or contain viral components when the nucleolus is disrupted and these abnormal complexes could initiate an autoimmune response when exposed to the immune system. Epitope spreading could then lead to an autoimmune reaction to the more abundant normal complexes. Many autoantigens reported in lupus and other autoimmune diseases are, at least transiently, nucleolar components.
Literatur
2.
Zurück zum Zitat Barr ML, Bertram EG. A morphological distinction between neurons of the male and female, and the behaviour of the nucleolar satellite during accelerated nucleoprotein synthesis. Nature. 1949;163:676–7.CrossRefPubMed Barr ML, Bertram EG. A morphological distinction between neurons of the male and female, and the behaviour of the nucleolar satellite during accelerated nucleoprotein synthesis. Nature. 1949;163:676–7.CrossRefPubMed
3.
Zurück zum Zitat Zhang LF, Huynh KD, Lee JT. Perinucleolar targeting of the inactive X during S phase: evidence for a role in the maintenance of silencing. Cell. 2007;129:693–706.CrossRefPubMed Zhang LF, Huynh KD, Lee JT. Perinucleolar targeting of the inactive X during S phase: evidence for a role in the maintenance of silencing. Cell. 2007;129:693–706.CrossRefPubMed
5.
Zurück zum Zitat Brooks WH, Renaudineau Y. The ‘nucleolus’ hypothesis of autoimmune diseases and its implications. Eur. Med J. 2017;2:82–9. Brooks WH, Renaudineau Y. The ‘nucleolus’ hypothesis of autoimmune diseases and its implications. Eur. Med J. 2017;2:82–9.
6.
Zurück zum Zitat Brooks WH. A review of autoimmune disease hypotheses with introduction of the “nucleolus” hypothesis. Clin Rev Allergy Immunol. 2017;52:333–50.CrossRefPubMed Brooks WH. A review of autoimmune disease hypotheses with introduction of the “nucleolus” hypothesis. Clin Rev Allergy Immunol. 2017;52:333–50.CrossRefPubMed
7.
Zurück zum Zitat Brooks W. Autoimmune diseases and polyamines. Clinic Rev Allerg Immu. 2012;42:58–70.CrossRef Brooks W. Autoimmune diseases and polyamines. Clinic Rev Allerg Immu. 2012;42:58–70.CrossRef
9.
Zurück zum Zitat Finestra TR, Bribnau J. X chromosome inactivation: silencing, topology and reactivation. Curr Opin Cell Biol. 2017;46:54–61.CrossRef Finestra TR, Bribnau J. X chromosome inactivation: silencing, topology and reactivation. Curr Opin Cell Biol. 2017;46:54–61.CrossRef
11.
Zurück zum Zitat Gendrel AV, Heard E. Noncoding RNAs and epigenetic mechanisms during X-chromosome inactivation. Ann Rev Cell Dev Biol. 2014;30:561–80.CrossRef Gendrel AV, Heard E. Noncoding RNAs and epigenetic mechanisms during X-chromosome inactivation. Ann Rev Cell Dev Biol. 2014;30:561–80.CrossRef
12.
Zurück zum Zitat Galupa R, Heard E. X-chromosome inactivation: new insights into cis and trans regulation. Curr Opin Genet Dev. 2015;31:57–66.CrossRefPubMed Galupa R, Heard E. X-chromosome inactivation: new insights into cis and trans regulation. Curr Opin Genet Dev. 2015;31:57–66.CrossRefPubMed
13.
Zurück zum Zitat Gendrel AV, Heard E. Fifty years of X inactivation research. Development. 2011;138:5049–55.CrossRefPubMed Gendrel AV, Heard E. Fifty years of X inactivation research. Development. 2011;138:5049–55.CrossRefPubMed
14.
Zurück zum Zitat Lyon MF. X-chromosome inactivation: a repeat hypothesis. Cytogenet Cell Genet. 1998;80:133–7.CrossRefPubMed Lyon MF. X-chromosome inactivation: a repeat hypothesis. Cytogenet Cell Genet. 1998;80:133–7.CrossRefPubMed
18.
Zurück zum Zitat McHugh CA, Chen CK, Chow A, Surka CF, Tran C, McDonel P, et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature. 2015;521:232–6.CrossRefPubMedPubMedCentral McHugh CA, Chen CK, Chow A, Surka CF, Tran C, McDonel P, et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature. 2015;521:232–6.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 2005;434:400–4.CrossRefPubMed Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 2005;434:400–4.CrossRefPubMed
21.
Zurück zum Zitat Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, et al. Hot L1s account for the bulk of retrotransposition in the human Population. Proc Natl Acad Sci U S A. 2003;100:5280–5.CrossRefPubMedPubMedCentral Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, et al. Hot L1s account for the bulk of retrotransposition in the human Population. Proc Natl Acad Sci U S A. 2003;100:5280–5.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Li JZ, Steinman CR. Plasma DNA in systemic lupus erythematosus. Arthritis Rheum. 1989;32:726–33.CrossRefPubMed Li JZ, Steinman CR. Plasma DNA in systemic lupus erythematosus. Arthritis Rheum. 1989;32:726–33.CrossRefPubMed
23.
Zurück zum Zitat Dewannieux M, Esnault C, Heidmann T. LINE-mediated retrotransposition of marked Alu sequences. Nat Genet. 2003;35:41–8.CrossRefPubMed Dewannieux M, Esnault C, Heidmann T. LINE-mediated retrotransposition of marked Alu sequences. Nat Genet. 2003;35:41–8.CrossRefPubMed
24.
Zurück zum Zitat Sawalha AH, Webb R, Han S, Kelly JA, Kaufman KM, Kimberly RP, et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One. 2008;3:e1727.CrossRefPubMedPubMedCentral Sawalha AH, Webb R, Han S, Kelly JA, Kaufman KM, Kimberly RP, et al. Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One. 2008;3:e1727.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Zhou Y, Yuan J, Pan Y, Fei Y, Qiu X, Hu N, et al. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin Immunol. 2009;132:362–70.CrossRefPubMedPubMedCentral Zhou Y, Yuan J, Pan Y, Fei Y, Qiu X, Hu N, et al. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin Immunol. 2009;132:362–70.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, et al. Sex-specific association of X-linked toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. PNAS. 2010;107:15838–43.CrossRefPubMedPubMedCentral Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, et al. Sex-specific association of X-linked toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. PNAS. 2010;107:15838–43.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Hewagama A, Gorelik G, Patel D, Liyanarachchi P, McCune WJ, Somers E, et al. Overexpression of X-linked genes in T cells from women with lupus. J Autoimmunity. 2013;41:60–71.CrossRef Hewagama A, Gorelik G, Patel D, Liyanarachchi P, McCune WJ, Somers E, et al. Overexpression of X-linked genes in T cells from women with lupus. J Autoimmunity. 2013;41:60–71.CrossRef
28.
Zurück zum Zitat Spriggs MK, Armitage RJ, Comeau MR, Strockbine L, Farrah T, Macduff B, et al. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J Virol. 1996;70:5557–63.PubMedPubMedCentral Spriggs MK, Armitage RJ, Comeau MR, Strockbine L, Farrah T, Macduff B, et al. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J Virol. 1996;70:5557–63.PubMedPubMedCentral
29.
Zurück zum Zitat O’Sullivan JM, Pai DA, Cridge AG, Engelke DR, Ganley ARD. The nucleolus: a raft adrift in the nuclear sea or the keystone in nuclear structure? BioMol Concepts. 2013;4:277–86.CrossRefPubMedPubMedCentral O’Sullivan JM, Pai DA, Cridge AG, Engelke DR, Ganley ARD. The nucleolus: a raft adrift in the nuclear sea or the keystone in nuclear structure? BioMol Concepts. 2013;4:277–86.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Padeken J, Heun P. Nucleolus and nuclear periphery: Velcro for heterochromatin. Curr Opin Cell Biol. 2014;28:54–60.CrossRefPubMed Padeken J, Heun P. Nucleolus and nuclear periphery: Velcro for heterochromatin. Curr Opin Cell Biol. 2014;28:54–60.CrossRefPubMed
31.
Zurück zum Zitat Grummt I. The nucleolus--guardian of cellular homeostasis and genome integrity. Chromosoma. 2013;122:487–97.CrossRefPubMed Grummt I. The nucleolus--guardian of cellular homeostasis and genome integrity. Chromosoma. 2013;122:487–97.CrossRefPubMed
33.
Zurück zum Zitat O’Day DH, Catalano A. Proteins of the nucleolus: an introduction. In: O’Day D, Catalano A, editors. Proteins of the nucleolus. Dordrecht: Springer; 2013. p. 3–15.CrossRef O’Day DH, Catalano A. Proteins of the nucleolus: an introduction. In: O’Day D, Catalano A, editors. Proteins of the nucleolus. Dordrecht: Springer; 2013. p. 3–15.CrossRef
35.
Zurück zum Zitat Lam YW, Trinkle-Mulcahy L. New insights into nucleolar structure and function. F1000 Prime Rep. 2015;7:48–57.CrossRef Lam YW, Trinkle-Mulcahy L. New insights into nucleolar structure and function. F1000 Prime Rep. 2015;7:48–57.CrossRef
38.
Zurück zum Zitat Hernandez-Verdun D, Roussel P, Thiry M, Sirri V, Lafontaine DLJ. The nucleolus: structure/function relationship in RNA metabolism. WIREs RNA. 2010;1:415–31.CrossRefPubMed Hernandez-Verdun D, Roussel P, Thiry M, Sirri V, Lafontaine DLJ. The nucleolus: structure/function relationship in RNA metabolism. WIREs RNA. 2010;1:415–31.CrossRefPubMed
39.
Zurück zum Zitat Goyns MH. Relationship between polyamine accumulation and RNA biosynthesis and content during the cell cycle. Experientia. 1981;37:34–5.CrossRefPubMed Goyns MH. Relationship between polyamine accumulation and RNA biosynthesis and content during the cell cycle. Experientia. 1981;37:34–5.CrossRefPubMed
41.
Zurück zum Zitat Salvetti A, Greco A. Viruses and the nucleolus: the fatal attraction. Biochim Biophys Acta. 2014;1842:840–7.CrossRefPubMed Salvetti A, Greco A. Viruses and the nucleolus: the fatal attraction. Biochim Biophys Acta. 2014;1842:840–7.CrossRefPubMed
44.
Zurück zum Zitat Kaiser C, Laux G, Eick D, Jochner N, Bornkamm GW, Kempkes B. The proto-oncogene c-myc is a direct target of gene of Epstein-Barr virus nuclear antigen 2. J Virol. 1999;73:4481–4.PubMedPubMedCentral Kaiser C, Laux G, Eick D, Jochner N, Bornkamm GW, Kempkes B. The proto-oncogene c-myc is a direct target of gene of Epstein-Barr virus nuclear antigen 2. J Virol. 1999;73:4481–4.PubMedPubMedCentral
47.
Zurück zum Zitat Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol. 2005;7:311–8.CrossRefPubMed Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol. 2005;7:311–8.CrossRefPubMed
48.
Zurück zum Zitat Gomez-Roman N, Grandori C, Eisenman RN, White RJ. Direct activation of RNA polymerase III transcription by c-Myc. Nature. 2003;421:290–4.CrossRefPubMed Gomez-Roman N, Grandori C, Eisenman RN, White RJ. Direct activation of RNA polymerase III transcription by c-Myc. Nature. 2003;421:290–4.CrossRefPubMed
49.
Zurück zum Zitat Yaniv G, Twig G, Shor DBA, Furer A, Sherer Y, Mozes O, et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev. 2015;14:75–9.CrossRefPubMed Yaniv G, Twig G, Shor DBA, Furer A, Sherer Y, Mozes O, et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev. 2015;14:75–9.CrossRefPubMed
50.
Zurück zum Zitat Reichlin M. Systemic lupus erythematosus. In Systemic autoimmunity. In: Bigazzi PE, Reichlin M, editors. , vol. 54. New York: Marcel Dekker; 1991. p. 163–200. Reichlin M. Systemic lupus erythematosus. In Systemic autoimmunity. In: Bigazzi PE, Reichlin M, editors. , vol. 54. New York: Marcel Dekker; 1991. p. 163–200.
51.
Zurück zum Zitat Li XZ, McNeilage LJ, Whittingham S. Autoantibodies to the major nucleolar phosphoprotein B23 define a novel subset of patients with anticardiolipin antibodies. Arthritis Rheum. 1989;32:1165–9.CrossRefPubMed Li XZ, McNeilage LJ, Whittingham S. Autoantibodies to the major nucleolar phosphoprotein B23 define a novel subset of patients with anticardiolipin antibodies. Arthritis Rheum. 1989;32:1165–9.CrossRefPubMed
52.
Zurück zum Zitat Wang Y, Xie J, Liu Z, Fu H, Huo Q, Gu Y, et al. Association of calreticulin expression with disease activity and organ damage in systemic lupus erythematosus patients. Exp Therap Med. 2017;13:2577–83.CrossRef Wang Y, Xie J, Liu Z, Fu H, Huo Q, Gu Y, et al. Association of calreticulin expression with disease activity and organ damage in systemic lupus erythematosus patients. Exp Therap Med. 2017;13:2577–83.CrossRef
53.
Zurück zum Zitat Nagai T, Arinuma Y, Yanaagida T, Yamamoto K, Hirohata S. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes. Arthritis Rheum. 2005;52:847–55.CrossRefPubMed Nagai T, Arinuma Y, Yanaagida T, Yamamoto K, Hirohata S. Anti-ribosomal P protein antibody in human systemic lupus erythematosus up-regulates the expression of proinflammatory cytokines by human peripheral blood monocytes. Arthritis Rheum. 2005;52:847–55.CrossRefPubMed
54.
Zurück zum Zitat Lassoued K, Guilly MN, Danon F, Andre C, Dhumeaux D, Clauvel JP, et al. Antinuclear autoantibodies specific for lamins: characterization and clinical significance. Ann Intern Med. 1988;108:829–33.CrossRefPubMed Lassoued K, Guilly MN, Danon F, Andre C, Dhumeaux D, Clauvel JP, et al. Antinuclear autoantibodies specific for lamins: characterization and clinical significance. Ann Intern Med. 1988;108:829–33.CrossRefPubMed
55.
Zurück zum Zitat Hengstman GJD, Ter Laak HJ, Egberts WTMV, Lundberg IE, Moutsopoulos HM, Vencovsky J, et al. Anti-signal recognition particle autoantibodies: marker of a necrotizing myopathy. Rheum Dis. 2006;65:1635–8.CrossRef Hengstman GJD, Ter Laak HJ, Egberts WTMV, Lundberg IE, Moutsopoulos HM, Vencovsky J, et al. Anti-signal recognition particle autoantibodies: marker of a necrotizing myopathy. Rheum Dis. 2006;65:1635–8.CrossRef
56.
Zurück zum Zitat Okano Y, Medsger TA. Autoantibody to the ribonucleoprotein (nucleolar 7–2 rna protein particle) in patients with systemic sclerosis. Arthritis Rheum. 1990;33:1822–8.CrossRefPubMed Okano Y, Medsger TA. Autoantibody to the ribonucleoprotein (nucleolar 7–2 rna protein particle) in patients with systemic sclerosis. Arthritis Rheum. 1990;33:1822–8.CrossRefPubMed
57.
Zurück zum Zitat Okano Y, Steen VD, Medsger TA. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum. 1992;35:95–100.CrossRefPubMed Okano Y, Steen VD, Medsger TA. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum. 1992;35:95–100.CrossRefPubMed
58.
Zurück zum Zitat Kipnis RJ, Craft J, Hardin JA. The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays. Arthritis Rheum. 1990;33:1431–7.CrossRefPubMed Kipnis RJ, Craft J, Hardin JA. The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays. Arthritis Rheum. 1990;33:1431–7.CrossRefPubMed
59.
Zurück zum Zitat Okano Y, Steen VD, Medsger TA. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med. 1993;119:1005–13.CrossRefPubMed Okano Y, Steen VD, Medsger TA. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med. 1993;119:1005–13.CrossRefPubMed
60.
Zurück zum Zitat Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA. Serum autoantibody to the nucleolar antigen PM-Scl: clinical and immunogenetic associations. Arthritis Rheum. 1992;35:1211–7.CrossRefPubMed Oddis CV, Okano Y, Rudert WA, Trucco M, Duquesnoy RJ, Medsger TA. Serum autoantibody to the nucleolar antigen PM-Scl: clinical and immunogenetic associations. Arthritis Rheum. 1992;35:1211–7.CrossRefPubMed
61.
Zurück zum Zitat Reimer G, Steen VD, Penning CA, Medsger TA, Tan EM. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum. 1988;31:525–32.CrossRefPubMed Reimer G, Steen VD, Penning CA, Medsger TA, Tan EM. Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum. 1988;31:525–32.CrossRefPubMed
62.
Zurück zum Zitat Jarjour WN, Minota S, Roubey RAS, Mimura T, Winfield JB. Autoantibodies to nucleolin cross-react with histone H1 in systemic lupus erythematosus. Mol Biol Rep. 1992;16:263–6.CrossRefPubMed Jarjour WN, Minota S, Roubey RAS, Mimura T, Winfield JB. Autoantibodies to nucleolin cross-react with histone H1 in systemic lupus erythematosus. Mol Biol Rep. 1992;16:263–6.CrossRefPubMed
64.
Zurück zum Zitat Yang F, Deng X, Ma W, Berletch JB, Rabaia N, Wei G, et al. The lncRNA Firre anchors the inactive X chromosome to the nucleolus by binding. Genome Biol. 2015;16(52):52.CrossRefPubMedPubMedCentral Yang F, Deng X, Ma W, Berletch JB, Rabaia N, Wei G, et al. The lncRNA Firre anchors the inactive X chromosome to the nucleolus by binding. Genome Biol. 2015;16(52):52.CrossRefPubMedPubMedCentral
65.
Zurück zum Zitat Caudron-Herger M, Pankert T, Seiler J, Németh A, Voit R, Grummt I, et al. Alu element-containing RNAs maintain nucleolar structure and function. EMBO J. 2015;34:2758–74.CrossRefPubMedPubMedCentral Caudron-Herger M, Pankert T, Seiler J, Németh A, Voit R, Grummt I, et al. Alu element-containing RNAs maintain nucleolar structure and function. EMBO J. 2015;34:2758–74.CrossRefPubMedPubMedCentral
68.
Zurück zum Zitat Neidhart M, Karouzakis E, Jungel A, Gay RE, Gay S. Inhibition of spermidine/spermine N1-acetyltransferase activity: a new therapeutic concept in rheumatoid arthritis. Mol Cell. 2014;66:1723–33. Neidhart M, Karouzakis E, Jungel A, Gay RE, Gay S. Inhibition of spermidine/spermine N1-acetyltransferase activity: a new therapeutic concept in rheumatoid arthritis. Mol Cell. 2014;66:1723–33.
Metadaten
Titel
Review of the “X chromosome-nucleolus nexus” hypothesis of autoimmune diseases with an update explaining disruption of the nucleolus
verfasst von
Wesley H. Brooks
Publikationsdatum
04.12.2018
Verlag
Springer US
Erschienen in
Immunologic Research / Ausgabe 6/2018
Print ISSN: 0257-277X
Elektronische ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-018-9044-1

Weitere Artikel der Ausgabe 6/2018

Immunologic Research 6/2018 Zur Ausgabe

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Eingreifen von Umstehenden rettet vor Erstickungstod

15.05.2024 Fremdkörperaspiration Nachrichten

Wer sich an einem Essensrest verschluckt und um Luft ringt, benötigt vor allem rasche Hilfe. Dass Umstehende nur in jedem zweiten Erstickungsnotfall bereit waren, diese zu leisten, ist das ernüchternde Ergebnis einer Beobachtungsstudie aus Japan. Doch es gibt auch eine gute Nachricht.

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.